Evidence map›Paper›PMID 41245676›Full record

ArticleASM case reports2025

Invasive fusariosis after CD19 chimeric antigen receptor T-cell therapy.

Rita Wilson Dib, Annoir Shayya, Emily A Siegrist, Maria Alkozah, Brian Scott, José Henao-Cordero, Cindy McCloskey, Melanie Speckman, Jeffrey D McBride, Jennifer Holter-Chakrabarty and 1 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in ASM case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rita Wilson DibInfectious Diseases Section, Department of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.ORCID https://orcid.org/0000-0001-7110-8885
Annoir ShayyaDepartment of Hematology & Medical Oncology, Lebanese American University-Rizk Hospital, Beirut, Lebanon.
Emily A SiegristInfectious Diseases Section, Department of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Maria AlkozahInfectious Diseases Section, Department of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Brian ScottInfectious Diseases Section, Department of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
José Henao-CorderoInfectious Diseases Section, Department of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Cindy McCloskeyDepartment of Microbiology, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma, USA.
Melanie SpeckmanDepartment of Microbiology, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma, USA.
Jeffrey D McBrideDepartment of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Jennifer Holter-ChakrabartyHematology-Oncology Section, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Joseph SassineInfectious Diseases Section, Department of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.ORCID https://orcid.org/0000-0001-8730-8929

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Invasive fusariosis is rarely reported post-chimeric antigen receptor T-cell (CAR-T) therapy. We herein present a case of cutaneous invasive Case Summary: A 61-year-old woman with relapsed refractory diffuse large B-cell lymphoma and secondary hemophagocytic lymphohistiocytosis received CD19-CAR-T therapy. She developed grade 1 cytokine release syndrome (CRS) and grade 3 immune effector cell-associated neurotoxicity syndrome (ICANS), requiring dexamethasone and anakinra. Twenty-five days after CAR-T, she developed bilateral proximal thigh nodular lesions. Skin biopsy revealed hyphal structures with hyphal structures, and culture revealed Conclusion: Though rare, healthcare providers should maintain an index of suspicion for

Indexed as

CAR-Tcase reportFusariumskin nodules

Identifiers

PMID41245676
PMCPMC12466021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.